<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://the483.com/samsung-biologics-buys-polypeptide/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T21:50:55.000Z</news:publication_date>
      <news:title>Bought PolyPeptide for $1.8B in Samsung&apos;s Peptide Push</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/celsius-founders-ftc-165-million/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T21:24:36.000Z</news:publication_date>
      <news:title>Pay $16.5M: Celsius Founders Settle FTC Charges</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/windtre-italy-1-7-million-fine/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T20:55:05.000Z</news:publication_date>
      <news:title>Italy Fines WindTre €1.7M Over API Gaps</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/aliexpress-fined-625m-dsa/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T20:44:26.317Z</news:publication_date>
      <news:title>AliExpress Fined $625M Over Unsafe Toys, Cosmetics</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/kyverna-miv-cel-fda-bla-autoimmune/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T10:39:40.000Z</news:publication_date>
      <news:title>Kyverna&apos;s NIH-licensed CAR T nears first autoimmune nod</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/france-anj-blocks-polymarket/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-20T09:36:18.000Z</news:publication_date>
      <news:title>Orders French ISPs to Block Polymarket</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/gold-eagle-treasury-clearinghouse/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-19T20:29:37.000Z</news:publication_date>
      <news:title>Treasury Opens GOLD EAGLE Under EO 14409</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/novartis-fabhalta-full-fda-approval-igan/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-19T10:47:46.000Z</news:publication_date>
      <news:title>Novartis Locks Full FDA Nod for Fabhalta in Kidney Disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/insmed-tpip-6b-pah-case/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-19T10:15:12.000Z</news:publication_date>
      <news:title>Boosts $6B case for Insmed&apos;s TPIP</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/blossomhill-100m-ipo-tagrisso/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-19T09:33:47.000Z</news:publication_date>
      <news:title>BlossomHill Files for IPO to Chase AstraZeneca</news:title>
    </news:news>
  </url>
</urlset>